WEED Stock Overview
Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Canopy Growth Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$9.69 |
52 Week High | CA$26.00 |
52 Week Low | CA$3.74 |
Beta | 1.83 |
11 Month Change | -5.28% |
3 Month Change | -34.57% |
1 Year Change | 56.29% |
33 Year Change | -95.47% |
5 Year Change | -97.08% |
Change since IPO | -62.59% |
Recent News & Updates
Recent updates
We Think Canopy Growth (TSE:WEED) Has A Fair Chunk Of Debt
Aug 17Some Confidence Is Lacking In Canopy Growth Corporation (TSE:WEED) As Shares Slide 26%
Jun 15Canopy Growth Corporation's (TSE:WEED) 77% Share Price Surge Not Quite Adding Up
Apr 20More Unpleasant Surprises Could Be In Store For Canopy Growth Corporation's (TSE:WEED) Shares After Tumbling 28%
Feb 23Analysts Have Been Trimming Their Canopy Growth Corporation (TSE:WEED) Price Target After Its Latest Report
Feb 13Why We're Not Concerned Yet About Canopy Growth Corporation's (TSE:WEED) 42% Share Price Plunge
Dec 22Is Canopy Growth (TSE:WEED) A Risky Investment?
Sep 17With A 31% Price Drop For Canopy Growth Corporation (TSE:WEED) You'll Still Get What You Pay For
Apr 17Is Canopy Growth (TSE:WEED) Using Too Much Debt?
Mar 21Earnings Update: Canopy Growth Corporation (TSE:WEED) Just Reported And Analysts Are Trimming Their Forecasts
Feb 12Is Canopy Growth (TSE:WEED) Using Too Much Debt?
Dec 08Shareholder Returns
WEED | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | 11.4% | 5.9% | 3.2% |
1Y | 56.3% | 44.3% | 14.6% |
Return vs Industry: WEED exceeded the Canadian Pharmaceuticals industry which returned 44.3% over the past year.
Return vs Market: WEED exceeded the Canadian Market which returned 14.6% over the past year.
Price Volatility
WEED volatility | |
---|---|
WEED Average Weekly Movement | 10.2% |
Pharmaceuticals Industry Average Movement | 10.9% |
Market Average Movement | 8.0% |
10% most volatile stocks in CA Market | 16.8% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: WEED's share price has been volatile over the past 3 months.
Volatility Over Time: WEED's weekly volatility has decreased from 26% to 10% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 1,029 | David Klein | www.canopygrowth.com |
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices.
Canopy Growth Corporation Fundamentals Summary
WEED fundamental statistics | |
---|---|
Market cap | CA$814.62m |
Earnings (TTM) | -CA$602.30m |
Revenue (TTM) | CA$287.10m |
2.9x
P/S Ratio-1.4x
P/E RatioIs WEED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
WEED income statement (TTM) | |
---|---|
Revenue | CA$287.10m |
Cost of Revenue | CA$197.94m |
Gross Profit | CA$89.17m |
Other Expenses | CA$691.47m |
Earnings | -CA$602.30m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 12, 2024
Earnings per share (EPS) | -7.10 |
Gross Margin | 31.06% |
Net Profit Margin | -209.79% |
Debt/Equity Ratio | 105.3% |
How did WEED perform over the long term?
See historical performance and comparison